Intellia Therapeutics amends IPO

Intellia Therapeutics Inc., Cambridge, Mass. Business: Gene/Cell therapy, Genomics, Cancer Date announced: 2016-04-27 Type: IPO To be raised: Up to $90 million Shares: 5 million Price: $16-$18 Underwr...